Dactinomycin in Tanzania: NEMLIT level, who can prescribe it and STG references
Dactinomycin is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 1 section.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is dactinomycin available on the DukaDawa pharmacy network?
Not yet. Dactinomycin is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is dactinomycin on the NEMLIT, and who can prescribe it?
Yes. Dactinomycin is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.
- Level
- S (zonal, special and national hospitals)
- Category
- Antineoplastics, Immunosuppressives and Immunomodulators
- Listed forms
- Powder for injection: 500 micrograms in vial
- Page
- NEMLIT, p. 12
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is dactinomycin in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention dactinomycin in 1 section, most often section 22.2.5.2 Gynecological Malignancies > Gestational Trophoblastic Disease > Malignant type (Gestational Trophoblastic neoplasia—GTN) (p. 575). See the STG for treatment details.
- 22.2.5.2 Gynecological Malignancies > Gestational Trophoblastic Disease > Malignant type (Gestational Trophoblastic neoplasia—GTN), p. 575
Sections that mention Dactinomycin, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- Abiraterone acetateNEMLIT S · Not on the DukaDawa network yet
- AdalimumabNEMLIT S · Not on the DukaDawa network yet
- AfliberceptNEMLIT S · Not on the DukaDawa network yet
- AlfuzosinNEMLIT D · Not on the DukaDawa network yet
- AllopurinolNEMLIT B · Not on the DukaDawa network yet
- AnastrozoleNEMLIT S · Not on the DukaDawa network yet
- Antithymocyte globulin (ATG) (rabbit)NEMLIT S · Not on the DukaDawa network yet
- AtezolizumabNEMLIT S · Not on the DukaDawa network yet
All antineoplastics, immunosuppressives and immunomodulators on the NEMLIT
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.